BioInfra Life Science Inc. (XKON:266470)
South Korea
· Delayed Price · Currency is KRW
280.00
+15.00 (5.66%)
At close: Dec 5, 2025
BioInfra Life Science Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| Dec '25 Dec 4, 2025 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
| Debt / Equity Ratio | -8.67 | -91.12 | 0.15 | 0.14 | 0.06 |
| Asset Turnover | 0.23 | 0.21 | 0.26 | 0.16 | - |
| Quick Ratio | 1.66 | 1.87 | 3.72 | 3.30 | 20.98 |
| Current Ratio | 1.67 | 1.87 | 3.87 | 4.10 | 23.67 |
| Return on Equity (ROE) | -746.62% | -230.95% | -100.74% | -58.82% | - |
| Return on Assets (ROA) | -28.10% | -23.72% | -37.93% | -23.33% | - |
| Return on Capital (ROIC) | -37.22% | -30.83% | -52.27% | -26.34% | - |
| Return on Capital Employed (ROCE) | -57.90% | -47.10% | -79.00% | -56.90% | -35.90% |
| Buyback Yield / Dilution | 2.59% | 1.87% | -6.28% | -1.42% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.